Veronesi U, Cascinelli N
World Health Organization Melanoma Programme, National Tumor Institute, Milan, Italy.
Arch Surg. 1991 Apr;126(4):438-41. doi: 10.1001/archsurg.1991.01410280036004.
We analyzed the results at 8 years of an international, randomized, prospective study carried out by the World Health Organization Melanoma Programme aimed at evaluating the efficacy of 1-cm-margin excision of primary melanomas not thicker than 2 mm. Data for 612 patients were assessable; 305 were randomized to receive 1-cm-margin excision and 307 to receive wide excision (margins of greater than or equal to 3 cm). The major prognostic criteria were similar in the two groups. Breslow thickness was 0.99 mm in the narrow excision group and 1.02 mm in the wide excision group. Disease-free and overall survival rates (mean follow-up period, 90 months) were similar in the two groups. Only four patients had a local recurrence as a first relapse. All underwent narrow excision, and each had primary melanomas thicker than 1 mm.
我们分析了世界卫生组织黑色素瘤项目开展的一项国际随机前瞻性研究8年的结果,该研究旨在评估对厚度不超过2mm的原发性黑色素瘤进行1cm切缘切除的疗效。612例患者的数据可进行评估;305例被随机分配接受1cm切缘切除,307例接受广泛切除(切缘大于或等于3cm)。两组的主要预后标准相似。窄切缘切除组的 Breslow 厚度为0.99mm,广泛切除组为1.02mm。两组的无病生存率和总生存率(平均随访期90个月)相似。只有4例患者首次复发为局部复发。所有患者均接受了窄切缘切除,且每例患者的原发性黑色素瘤厚度均超过1mm。